Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.


TSX:AVCN - Post by User

Comment by Smattesonon Mar 27, 2021 5:18pm
92 Views
Post# 32893603

RE:RE:RE:RE:RE:Are the shorters right.

RE:RE:RE:RE:RE:Are the shorters right.This is fun! Naked shorts defending their position with gossip now....sad. You say you are not short but you creep the CEO's socia media and spend 12 months writing about the company, right...! 

You have been proven wrong every time and some samples below, its time to give it up. I know the guys, I have invested, I am long, I support the company, and hate dirty CAD hegde funds that can naked short and IROC does nothing. If not short what is your position? 12 months of negative comments, why? The truth is you guys went short, which was probably a good call considering the industry at the time, in this case you were proven wrong and this is more about your ego and preventing a massive squeeze than anything else. Sooner or later fundementals and execution blows you out of the water....I am waiting and will enjoy when that happens. This is a long term hold and a long term winner. 

-You previously mentioned they cannot raise money and are in a death spirall, proven wrong they raised through their network and didnt let you cover! Have lowered burn and have started revenue in several countries. 

-You mentioned they are pharma and wont make revenue for years, proven wrong and they will hit profitability this year!

-You mention Shoppers drug mart was a small market and they wont make money as they are exclusive, they expanded to adult use.

-As for salaries, total comp in that range is more than logical, what they took in cash, how much they lowered and deffered is what you are not talking about and the numbers will show. 

-Now you are picking on the mng, as you have nothing else left to say, frankly no one cares what you and your other social media trolls write on this portal, I just like proving you wrong. Note, Kyle Langstaff is not an exec, the rest have excercised rights, not sold a share, for 5 years both Setu and Aras have 2.5M shares + still! that is beyond impressive. Last 9 months 121 insider buys and 1 sell, again impressive.

On other hand, creeping their personal social media's is sad bud.....get a life. I understand that's your fund's MO, make stuff up, creep and find dirt, must be tough in this situation you have nothing. 

Here is the info read for yourselves folks! Compensation commitee is in place and its independent board members, they analyze vs peers and provide feedback on compensation, they are paid well below peers. 2019 CEO base salary was $240k, how much of that was deffered or reduced, we will find out in the next filings.  

https://sedar.com/GetFile.do?lang=EN&docClass=10&issuerNo=00044271&issuerType=03&projectNo=03117888&docId=4806000
<< Previous
Bullboard Posts
Next >>